These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9778488)

  • 1. Short-term treatment with a low dose of inhaled fluticasone propionate decreases the number of CD1a+ dendritic cells in asthmatic airways.
    Bocchino V; Bertorelli G; Zhuo X; Grima P; Di Comite V; Damia R; Chetta A; Del Donno M; Foresi A; Casalini A; Testi R; Olivieri D
    Pulm Pharmacol Ther; 1997; 10(5-6):253-9. PubMed ID: 9778488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 70 upregulation is related to HLA-DR expression in bronchial asthma. Effects of inhaled glucocorticoids.
    Bertorelli G; Bocchino V; Zhuo X; Chetta A; Del Donno M; Foresi A; Testi R; Olivieri D
    Clin Exp Allergy; 1998 May; 28(5):551-60. PubMed ID: 9645591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
    Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids.
    Möller GM; Overbeek SE; Van Helden-Meeuwsen CG; Van Haarst JM; Prens EP; Mulder PG; Postma DS; Hoogsteden HC
    Clin Exp Allergy; 1996 May; 26(5):517-24. PubMed ID: 8735863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell number is related to IL-4 expression in the airways of atopic asthmatic subjects.
    Bertorelli G; Bocchino V; Zhou X; Zanini A; Bernini MV; Damia R; Di Comite V; Grima P; Olivieri D
    Allergy; 2000 May; 55(5):449-54. PubMed ID: 10843425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.
    Booth H; Richmond I; Ward C; Gardiner PV; Harkawat R; Walters EH
    Am J Respir Crit Care Med; 1995 Jul; 152(1):45-52. PubMed ID: 7599861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time.
    Faul JL; Leonard CT; Burke CM; Tormey VJ; Poulter LW
    Thorax; 1998 Sep; 53(9):753-61. PubMed ID: 10319057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of montelukast compared with inhaled fluticasone on airway inflammation.
    Overbeek SE; O'Sullivan S; Leman K; Mulder PG; Hoogsteden HC; Prins JB
    Clin Exp Allergy; 2004 Sep; 34(9):1388-94. PubMed ID: 15347371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma.
    Hart L; Lim S; Adcock I; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 2000 Jan; 161(1):224-31. PubMed ID: 10619824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
    O'Sullivan S; Akveld M; Burke CM; Poulter LW
    Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
    Sheffer AL; LaForce C; Chervinsky P; Pearlman D; Schaberg A
    J Fam Pract; 1996 Apr; 42(4):369-75. PubMed ID: 8627205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone.
    Chetta A; Zanini A; Foresi A; Del Donno M; Castagnaro A; D'Ippolito R; Baraldo S; Testi R; Saetta M; Olivieri D
    Am J Respir Crit Care Med; 2003 Mar; 167(5):751-7. PubMed ID: 12468439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone propionate and bronchial hyperresponsiveness in childhood asthma.
    Direkwattanachai C; Limkittikul K; Kraisarin C; Sasisakulporn C; Benjaponpitak S
    Asian Pac J Allergy Immunol; 1999 Jun; 17(2):63-7. PubMed ID: 10466540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma.
    Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA
    J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway inflammation in asthma and chronic obstructive pulmonary disease with special emphasis on the antigen-presenting dendritic cell: influence of treatment with fluticasone propionate.
    Hoogsteden HC; Verhoeven GT; Lambrecht BN; Prins JB
    Clin Exp Allergy; 1999 Jun; 29 Suppl 2():116-24. PubMed ID: 10421834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.